We are live on ! Find out more
SCM

Silvant Capital Management Portfolio holdings

AUM $2.89B
1-Year Est. Return 34.45%
This Fund
S&P 500
This Quarter Est. Return
+1.23%
1 Year Est. Return
+34.45%
3 Year Est. Return
+148.47%
5 Year Est. Return
+205.7%
10 Year Est. Return
–
AUM
$560M
AUM Growth
-$74.7M
Cap. Flow
-$79.7M
Cap. Flow %
-14.23%
Top 10 Hldgs %
44.6%
Holding
340
New
9
Increased
8
Reduced
106
Closed
11

Top Buys

Rank Stock Value
1
DKNG icon
DraftKings
DKNG
+$1.29M
2
S icon
SentinelOne
S
+$1.15M
3
TSLA icon
Tesla
TSLA
+$1.08M
4
SPGI icon
S&P Global
SPGI
+$915K
5
UPS icon
United Parcel Service
UPS
+$856K

Top Sells

Rank Stock Value
1
MSFT icon
Microsoft
MSFT
+$8.47M
2
AAPL icon
Apple
AAPL
+$8.37M
3
AMZN icon
Amazon
AMZN
+$5.31M
4
EQIX icon
Equinix
EQIX
+$3.27M
5
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$3.15M

Sector Composition

Rank Sector Weight
1 Technology 31.93%
2 Healthcare 14.26%
3 Consumer Discretionary 14.14%
4 Financials 13.68%
5 Communication Services 12.49%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
FOLD
201
DELISTED
Amicus Therapeutics
FOLD
$154K 0.03%
16,168
– –
LSCC icon
202
Lattice Semiconductor
LSCC
$17.6B
$153K 0.03%
+2,360
New +$139K
NEE icon
203
NextEra Energy
NEE
$181B
$153K 0.03%
1,944
– –
NKE icon
204
Nike
NKE
$61.9B
$152K 0.03%
1,048
– –
TVRD
205
Tvardi Therapeutics
TVRD
$19.7M
$149K 0.03%
269
– –
AVY icon
206
Avery Dennison
AVY
$13B
$147K 0.03%
708
– –
PEP icon
207
PepsiCo
PEP
$190B
$146K 0.03%
971
– –
VFC icon
208
VF Corp
VFC
$5.63B
$142K 0.03%
2,127
– –
MS icon
209
Morgan Stanley
MS
$331B
$132K 0.02%
1,357
– –
BBIO icon
210
BridgeBio Pharma
BBIO
$15.7B
$129K 0.02%
2,746
– –
AFL icon
211
Aflac
AFL
$64.9B
$128K 0.02%
2,462
– –
EDIT icon
212
Editas Medicine
EDIT
$396M
$125K 0.02%
3,041
– –
PSA icon
213
Public Storage
PSA
$60.5B
$123K 0.02%
414
– –
PLCE icon
214
Children's Place
PLCE
$54.3M
$121K 0.02%
1,611
– –
ADP icon
215
Automatic Data Processing
ADP
$106B
$118K 0.02%
588
– –
DRI icon
216
Darden Restaurants
DRI
$23.3B
$111K 0.02%
733
– –
GE icon
217
GE Aerospace
GE
$374B
$111K 0.02%
1,735
-2
-0.1% -$129
GLW icon
218
Corning
GLW
$119B
$107K 0.02%
2,935
– –
SO icon
219
Southern Company
SO
$109B
$107K 0.02%
1,727
– –
MDGL icon
220
Madrigal Pharmaceuticals
MDGL
$10.8B
$103K 0.02%
1,291
– –
SKT icon
221
Tanger
SKT
$4.67B
$103K 0.02%
6,327
– –
AMT icon
222
American Tower
AMT
$80.8B
$102K 0.02%
382
– –
IP icon
223
International Paper
IP
$21.6B
$102K 0.02%
1,922
– –
NKTX icon
224
Nkarta
NKTX
$150M
$101K 0.02%
3,643
– –
AKRO
225
DELISTED
Akero Therapeutics
AKRO
$100K 0.02%
4,482
– –
7 8
9
10 11

Similar funds

AG
Ascent Group Virginia Beach, Virginia $2.89B AUM 19.6% 1-Year Est. Return
NRCM
North Reef Capital Management Laguna Beach, California $2.91B AUM 11.03% 1-Year Est. Return
BAM
BCV Asset Management Winnipeg $2.91B AUM
PFM
Potomac Fund Management Miami, Florida $2.88B AUM 15.75% 1-Year Est. Return
DMIC
Dixon Mitchell Investment Counsel Vancouver, British Columbia, Canada $2.88B AUM 18.53% 1-Year Est. Return
LIP
Lighthouse Investment Partners Palm Beach Gardens, Florida $2.87B AUM 26.77% 1-Year Est. Return
CCM
Chilton Capital Management Houston, Texas $2.87B AUM 25.44% 1-Year Est. Return
HCC
Hirtle Callaghan & Co West Conshohocken, Pennsylvania $2.92B AUM 17.65% 1-Year Est. Return

Silvant Capital Management's Q3 2021 Portfolio in Review

As of Q3 2021, Silvant Capital Management held 340 positions worth $560M, down 12% from $635M the previous quarter. Its ten largest holdings account for 45% of the portfolio.

Silvant Capital Management withdrew a net $79.7M in Q3 2021, closing 11 positions and reducing 106 holdings. Its most notable exit was Vertex Pharmaceuticals, an estimated $2.16M position sold in full.

By sector, the portfolio is most concentrated in Technology at 32% of assets, up from 32% a quarter earlier, followed by Healthcare and Consumer Discretionary.

Against the trend, Silvant Capital Management opened a new position in SentinelOne worth $1.13M.

  • Silvant Capital Management's largest Q3 2021 buy was SentinelOne: 21,028 shares worth $1.13M.
  • Silvant Capital Management added most to DraftKings in Q3 2021, an estimated $1.29M increase.
  • Silvant Capital Management's biggest Q3 2021 reduction was Microsoft, cutting an estimated $8.47M.
  • Silvant Capital Management fully exited Vertex Pharmaceuticals in Q3 2021, selling an estimated $2.16M.
  • Silvant Capital Management's ten largest holdings make up 45% of its $560M portfolio in Q3 2021.
  • Silvant Capital Management opened 9 new positions and closed 11 in Q3 2021.
  • Silvant Capital Management's portfolio value fell 12% quarter-over-quarter to $560M.

Based on Silvant Capital Management's 13F filing for Q3 2021, filed 8 Nov 2021.